Pasar al contenido principal

DESARROLLO DE NANOPARTICULAS ZWITERIONICAS DE POLI(BETA-AMINOESTER) COMO VACUNAS DE MRNA PARA TRATAR EL CANCER DE PULMON DE CELULAS NO PEQUEÑAS

PID2021-125910OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT RAMON LLULL, FUNDACIO PRIVADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 36
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Safety of nanoparticle therapies during pregnancy: a systematic review and meta-analysis

  • Gil-Vives, Maria
  • Hernández, Marta
  • Hernáez, Álvaro
  • Borrós, Salvador
  • Fornaguera, Cristina
The exclusion of pregnant women from clinical trials has led to insufficient safety data for many treatments, making it necessary to evaluate their potential benefits and risks during preclinical stages. Nanomedicines show potential for reduced toxicity but there is limited evidence about their safety for pregnant women and their fetuses. We conducted the first systematic review and meta-analysis of the effect of nanoparticles (NPs) on a key outcome of fetal toxicity (low birth weight) in murine models. In the meta-analysis of mouse models, negatively charged NPs tended to decrease birth weight (-69.8 mg, 95 % CI: -196 to 56.5), as did small (-191 mg, 95 % CI: -369 to -13.3) and plain inorganic nanosystems (-249 mg, 95 % CI: -535 to 37.4). In contrast, positively charged NPs resulted in increased birth weight (+29.3 mg, 95 % CI: 23.4 to 35.2). All findings were validated in studies with low heterogeneity and low risk of publication bias. Neither large NPs (+4.37 mg; 95 % CI: -45.3 to 54.0) nor polymer-coated NPs (+16.5 mg; 95 % CI: -44.7 to 77.6) had any clear association with birth weight. Similar results were observed in other models and experimental designs from articles not included in the meta-analysis, although no conclusions were drawn for other parameters due to high variability. Our findings pave the way for future research and the rational development of safer nanomedicines for use during pregnancy., Agencia Estatal de Investigación MICIN / AEI, grants: PID2021-125910OB-I00, MCIN/AEI and 10.13039/501100011033 / FEDER, UE (CFP).
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Localized doxycycline delivery via polymeric nanoparticles anchored to electrospun PCL microfiber patch for MMP-2 inhibition in abdominal aortic aneurysm

  • Bofill Bonet, Carles
  • Febas, Germán
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà Palasí, Noemí
  • Martorell, Jordi
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxycycline (DOXY) is a well-established antibiotic that has recently shown potential in inhibiting matrix metalloproteinase-2 (MMP-2), a key enzyme involved in the progression of abdominal aortic aneurysms (AAA). However, the controlled delivery of DOXY to the aneurysm site, with sustained release and minimal systemic exposure, remains a critical challenge in therapeutic development. To address this, we developed a targeted drug delivery platform based on polymeric nanoparticles (NPs), prepared from water-in-oil-in-water nano-emulsions, encapsulating DOXY and are covalently attached to electrospun ε-poly(caprolactone) (ε-PCL) microfibers. This system was designed to enable local, sustained drug release in the inner wall of aorta while preserving the mechanical properties of the aortic wall. The ε-PCL electrospun microfibers from the patch were first functionalized using oxygen cold plasma treatment, creating free radicals that enabled covalent bonding with chemical groups on the outer layer of DOXY-loaded poly(lactic-co-glycolic acid) (PLGA) NPs. This strategy allowed for robust immobilization of the NPs onto the microfibers surface, forming a composite system capable of localized and controlled drug release over time. Unlike traditional delivery approaches, this method ensures site-specific action of DOXY directly at the aneurysmal tissue, minimizing systemic circulation and reducing off-target toxicity. The platform not only provides a stable drug reservoir but also offers intrinsic biomechanical reinforcement, which is critical in AAA condition. This innovative delivery system represents a significant advance in the localized treatment of vascular disorders. It offers a biocompatible, biodegradable, and precisely targeted therapeutic approach, with potential to reduce the need for surgical intervention and limits the adverse effects associated with systemic drug administration., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Novel α-mannose-functionalized poly(β-amino ester) nanoparticles as mRNA vaccines with increased antigen presenting cell selectivity in the spleen

  • González-Ríos, Nil
  • Artigues Cladera, Margalida
  • Guerra-Rebollo, Marta
  • Planas, Antoni
  • Borrós, Salvador
  • Faijes, Magda
  • Fornaguera, Cristina
mRNA vaccination has emerged as a prominent therapy for the future of medicine. Despite the colossal advance in this technology and worldwide efficacy proof (ca. COVID vaccines), mRNA carriers still lack cell/tissue specificity, leading to possible side effects, and reduced efficacy among others. Herein we make use of the ubiquitous affinity of antigen-presenting cells (APC)s for glycosides to achieve specific targeting. To achieve this goal, we designed a new generation of α-mannosyl functionalized oligopeptide-terminated poly(β-aminoester). Fine formulation of these polymers with mRNA resulted in nanoparticles decorated with surface-exposed α-mannoses with sizes around 180 nm and positive surface charge. Notably, these particles maintained their properties after freeze-drying and subsequent redispersion. Finally, our mRNA carriers preferentially targeted and transfected APCs in vitro and in vivo. In conclusion, we demonstrated, at a preclinical level, that the mannose functionalization enables more selective targeting of APCs and, thus, these polymer and nanoparticles are candidates for a new generation of mRNA immunotherapy vaccines., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles

  • Guarro, Monica
  • van Veen, Stijn
  • Borrós, Salvador
  • Albertazzi, Lorenzo
  • Lecina, Martí
  • Fornaguera, Cristina
Extracellular vesicles (EVs) are increasingly recognized as natural therapeutic delivery systems (DDS). A critical challenge in realizing this potential is the loading of nucleic acids, particularly mRNA, a high molecular weight and very sensitive biomolecule, for which the loading efficiency into EVs is often low. Despite the growing interest in EV-based delivery platforms, relatively few studies have reported efficient loading techniques, and inconsistent or misleading information in the literature hinders progress towards the development of reliable loading of mRNA into EV-based systems. Addressing this gap systematically and quantitatively is crucial for the clinical translation of EVs as DDS. In this study, we compared five different exogenous mRNA loading methods (incubation, sonication, freeze-thaw, electroporation and extrusion) and evaluated their loading efficiencies, as well as their biophysical, biochemical, and functional properties. Here, using direct stochastic optical reconstruction microscopy (dSTORM), as an efficient and reliable characterization approach to assess mRNA loading efficiency into EVs we visualized single EVs and single mRNA molecules and to estimate the percentage of loaded EVs as well as the amount of mRNA molecules loaded per EV. Interestingly, all five strategies demonstrated a high yield of EVs associated with mRNA, with up to 70 % of EVs successfully containing or in contact with mRNA, with minimal disruption to the intrinsic properties of EVs. Although some discrepancies between loading efficiencies, functionality and amount of mRNA molecules per EV, freeze-thaw proved to be the most effective in terms of loading efficiency and amount of mRNA associated molecules per EV. Overall, mRNA incorporation using these exogenous methods remained inefficient and presented significant challenges for large-scale implementation due to substantial mRNA loss. Despite this limitation, the high proportion of successfully loaded or mRNA associated EVs, particularly with freeze-thaw and electroporation, provides, for the first time, a promising foundation for the advancing of mRNA loading on EV-based therapeutic applications., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

PExM: polyplex expansion microscopy for cell trafficking studies

  • Navalón López, María
  • Castells Colldeforns, Pau
  • Pujals, Sílvia
  • Fornaguera, Cristina
  • Borrós, Salvador
Nanomedicine is a field at the intersection of nanotechnology and medicine, promising due to its potential to revolutionize healthcare. Despite its long trajectory, there is still a long road ahead for its full development, and smart design of nanomedicines is still a challenge. Among other problems, this is due to the scarcity of tools available for the precise visualization and comprehension of nano–bio interactions, impeding progress towards the clinical phase. One of the developed tools that stands out to be a strong nanoscopy technique for studying nano-delivery systems within cellular environments is expansion microscopy (ExM). This technique was used for tissue and cell expansion and most recently for lipid molecule expansion inside cells. Herein, we present for the first time polyplex expansion microscopy (PExM); a comprehensive examination of ExM as an already developed technique, but adapted for expanding polymer based nanocarriers, in particular polyplexes within cells, allowing the analysis of their trafficking. With our method set up, PExM will be extensively used for the study of polyplex nanoparticle cell trafficking, becoming a high-resolution technique which can also be applied to primary amine containing polymeric nanoparticles without requiring expensive super-resolution microscopes., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Ammonium trifluoroborate-modified poly(β-aminoesters): A case study for PET-guided in vivo pharmacokinetic studies of a non-viral gene delivery system

  • Cosialls, Raúl
  • Fernández, Odile
  • Simó , Cristina
  • Krishna Reddy, Pulagam
  • Guerra-Rebollo, Marta
  • Llop, Jordi
  • Fornaguera, Cristina
  • Cuenca, Ana Belen
  • Borrós, Salvador
Nucleic acid-based therapies have become a game-changing player in our way of conceiving pharmacology. Nevertheless, the inherent lability of the phosphodiester bond of the genetic material with respect to the blood nucleases severely hampers its delivery in naked form, therefore making it necessary to use delivery vectors. Among the potential non-viral vectors, polymeric materials such as the poly(β-aminoesters) (PBAEs) stand out as promising gene carriers thanks to their ability to condense nucleic acids in the form of nanometric polyplexes. To keep advancing these systems into their translational preclinical phases, it would be highly valuable to gain accurate insights of their in vivo pharmacokinetic profile. We envisaged that positron emission tomography (PET)-guided imaging could provide us with both, an accurate assessment of the biodistribution of PBAE-derived polyplexes, as well shed light on their clearance process. In this sense, taking advantage of the efficient [19F]-to-[18F]‑fluorine isotopic exchange presented by the ammonium trifluoroborate (AMBF3) group, we have designed and synthesized a new 18F-PET radiotracer based on the chemical modification of a linear poly(β-aminoester). As proof of concept, the incorporation of the newly developed 18F-PBAE into a model nanoformulation was shown to be fully compatible with the formation of the polyplexes, their biophysical characterization, and all their in vitro and in vivo functional features. With this tool in hand, we were able to readily obtain key clues about the pharmacokinetic behavior of a series of oligopeptide-modified PBAEs (OM-PBAEs). The observations described in this study allow us to continue supporting these polymers as an outstanding non-viral gene delivery vector for future applications., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers

  • Fernandez Alarcon, Jennifer
  • Rata Karusan , Nisha
  • Presciutti, Clara
  • Miras, Jonathan
  • Magana Rodriguez, Jose Rodrigo
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Ahmad, Noraini
  • Fornaguera, Cristina
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovitis, systemic inflammation and autoantibodies, leading to joint damage and disability. RA pathogenesis is characterized by a dysregulated interaction between immune cells, particularly B cells and T cells, which release inflammatory cytokines. This review explores the pivotal role of these immune cells in sustaining the inflammatory response and contributing to tissue injury. We provide a comprehensive overview of current RA therapies, highlighting the limitations of conventional treatments and the pressing need for targeted drug delivery systems such as lipid nanocarrier-based therapies, including nano-emulsions, solid lipid nanoparticles (SLNs), niosomes, liposomes, transferosomes, and ethosomes. Emphasizing niosomes, we discuss their capacity to encapsulate multiple drugs, significantly enhancing bioavailability and therapeutic efficacy. By directing drug-loaded niosomes to inflamed synovial sites, this innovative approach minimizes systemic side effects while maximizing localized drug concentrations, thereby optimizing treatment outcomes for RA patients. This review underscores the importance of targeted (nano)drug delivery in improving patient's life quality and represents a significant step toward more effective, personalized RA therapies by deepening our understanding of the underlying mechanisms., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Balancing stability and cellular interaction in surface-engineered small extracellular vesicles for pulmonary delivery

  • Gomez Sanchez, Jose
  • Leivar, Pablo
  • Pinto, Soraia
  • Almeida, Helena
  • Artigues Cladera, Margalida
  • Sarmento, Bruno
  • Lecina, Martí
  • Fornaguera, Cristina
Small extracellular vesicles (sEVs) are emerging as promising nanocarriers for non-invasive pulmonary drug delivery, yet their effectiveness is limited by sequential barriers imposed by airway mucus and the pulmonary epithelium-endothelium interface. Here, we investigated how post-secretory surface engineering with exogenous phospholipids modulates sEVs transport across lung-relevant barriers. eGFP-CD81 engineered sEVs were post-secretory modified at their surface composition using different lipid-to-vesicle ratios of either the zwitterionic lipid 1,2- Dilauroyl-sn-glycero-3-phosphocholine (DLPC) or the PEGylated lipid 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) -PEG(5000) - Azide (DPA). Both modifications enabled controlled tuning of surface charge and colloidal stability without altering vesicle size at optimized lipid-to-vesicle ratios, although excessive DPA induced aggregation. The physicochemical properties and transport behaviour of engineered sEVs were evaluated in a reconstituted mucin gel and a 3D pulmonary epithelial-endothelial co-culture model. In mucin-containing medium, lipid-engineered sEVs showed enhanced diffusion compared with unmodified vesicles, with DLPC at a 30,000:1 ratio providing the highest cumulative permeability, sustained apparent permeability coefficients, and more diffusive motion profiles, as confirmed by multiple particle tracking. In the 3D co-culture, the same modification achieved the greatest cumulative permeability and basolateral accumulation, indicating efficient transcellular passage, while DPA-functionalized vesicles displayed moderate permeability and predominant retention at the apical epithelial layer. Through fluorescently-labelling EVs, we confirmed that all formulations were internalized by apical cells, but only DLPC-engineered sEVs reached detectable levels in basolateral cells. Neither DLPC nor DPA affected cell viability or barrier morphology. Overall, our results identify DLPC at 30,000:1 as a lead formulation that balances mucus penetration and efficient crossing of the pulmonary barrier, while DPA is better suited for applications requiring strong epithelial engagement. Our findings highlight rational phospholipid engineering as a powerful approach to tailor sEVs-based nanomedicines for pulmonary delivery., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

A dual QTOF–QTrap analytical platform for comprehensive tracking of doxycycline and its degradation byproducts in biological and nanoparticle-based delivery systems

  • Bofill Bonet, Carles
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà, Noemí
  • Martorell, Jordi
  • Fornaguera, Cristina
  • Borrós, Salvador
Doxycycline (DOX) is a second-generation tetracycline antibiotic extensively used in clinical practice, not only for its antimicrobial activity but also for its emerging therapeutic potential in modulating extracellular matrix (ECM) in remodeling processes. Increasing evidence supports its role in attenuating pathological conditions associated with ECM degradation by targeting matrix metalloproteinases type 2 (MMP-2), including cancer progression and abdominal aortic aneurysm (AAA). However, DOX exhibits limited stability in aqueous and semi-physiological environments, undergoing hydrolysis and oxidative reactions that lead to the generation of multiple degradation byproducts, thereby compromising its efficacy and safety profile. In this study, we systematically mapped the degradation pathways of DOX under rigorously controlled physicochemical and biological conditions. High-resolution QTOF mass spectrometry operating in SWATH data-independent acquisition mode enabled unbiased identification of multiple, structurally distinct degradation byproducts, as well as the DOX parent compound, using curated metabolite libraries from SCIEX platform. Building on this annotation step, we established a complementary QTrap-based targeted workflow to quantify low-abundance metabolites intra- and extracellular through isotope-specific transitions derived from the QTOF analysis and to monitor their temporal kinetics with high sensitivity. Together, this integrated analytical strategy provides refined insight into the intrinsic instability of DOX and its potential biological consequences. To translate degradation mapping into a biologically relevant context, OM-PLGA NPs were incorporated as a controlled delivery platform that modulates DOX exposure, slows spontaneous degradation, and creates the matrix conditions required to validate the sensitivity of the QTRAP workflow in complex cellular environments. This validation demonstrated that OM-PLGA nanoparticles not only preserve DOX in its bioactive form through microenvironmental shielding, but also results in enhanced pharmacological activity, particularly sustained inhibition of MMP-2, a central enzyme in AAA-associated ECM remodeling. Together, these results highlight the dual value of the advanced analytical workflow and the nanocarrier strategy, demonstrating how integrating high-resolution mass spectrometry with nanoparticle engineering overcomes the intrinsic instability of DOX and provides deeper mechanistic insight across both analytical and biological dimensions., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from Plectranthus grandidentatus Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera
  • Morais, João
  • Fernandez Alarcon, Jennifer
  • S. Viana, Ana
  • Reis, Catarina
  • Pereira Leite, Catarina
  • Ana M., Díaz Lanza
  • Saraiva, Lucília
  • Fornaguera, Cristina
  • Rijo, Patrícia Dias de Mendonça
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization

  • Losada Baranera, Mar
  • GOTOR, GEMMA
  • Borrós, Salvador
  • Fornaguera, Cristina
Messenger RNA (mRNA) has emerged as a transformative modality for modern therapeutics, including vaccines and gene therapies. Ensuring the quality, safety, and efficacy of mRNA products requires the evaluation of critical quality attributes (CQAs) such as sequence integrity, nucleotide modifications, purity, and structural stability. The growing complexity of modified mRNA therapeutics highlights the need for robust and orthogonal analytical strategies. This review summarizes liquid chromatography (LC)-based workflows tailored for mRNA characterization including UV detection and mass spectrometry (MS) strategies. These include nucleoside-level analysis to identify chemical modifications and impurities, partial digestion with oligonucleotide mapping to assess sequence coverage and localization of modifications, and intact mRNA analysis to evaluate global structural integrity and encapsulation efficiency. Case studies illustrate practical applications by directly linking analytical workflows to specific CQAs and regulatory-relevant attributes. By leveraging advances in chromatography and mass spectrometry—including bioinert stationary phases, high-resolution detection, and ion-pairing strategies—these studies enable robust analysis of highly polar, charged, and high-molecular-weight mRNA species. The integration of complementary chromatographic and MS-based workflows supports comprehensive characterization, facilitates regulatory compliance, and informs process and formulation development, ultimately providing a coherent framework for quality control in emerging mRNA therapeutics., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Regulation of mitochondrial apoptosis via siRNA-loaded metallo-alginate hydrogels: A localized and synergistic antitumor therapy

  • Fernandez Alarcon, Jennifer
  • Artigues Cladera, Margalida
  • Rodriguez Camenforte, Natalia
  • Sitia, Giovanni
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Preventing relapse after resection of a primary tumor continues to be an unmet clinical need. Development of adjuvant biomaterials with the capacity to kill residual cancer cells after tumor resection is of clinical importance. Here we developed a library of metallo-alginate hydrogels containing high concentrations of metallic ions such as Ca2+ in combination with Zn2+, Li+, or Mg2+ to disrupt Ca2+ homeostasis in the mitochondria of cancer cells by local hyperthermia. To synergistically kill tumor cells and suppress the growth of rechallenged tumors, we embedded oncogene-silencing nucleic acids (mTOR siRNA) loaded into polymerc nanoparticles (NPs) composed of poly (β-amino esters) in the metallo-alginate hydrogels, targeting cancer cells that activate multi-drug resistance pathways such PI3K/AKT/mTOR. Metabolomic studies showed alterations in the Warburg effect, mitochondrial transport, and the TCA cycle, confirming cancer cell damage. In vivo studies of this targeted therapy in mice demonstrated a sex-dependent effect. Male B16F10-tumor-bearing mice treated with the synergistic therapy showed restrained tumor growth. In contrast, no therapeutic effect was observed in female counterparts. Our results demonstrate that in situ-formed NP-loaded metallo-alginate hydrogels can modulate two distinct immune signaling networks that are relevant for enhancing cancer cell death. On the basis of our findings, this combination therapy emerges as a promising sex-dependent strategy for clinical translation., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics, the good, the bad, and the future

  • Magana Rodriguez, Jose Rodrigo
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Immunotherapy has emerged as a promising approach to cancer treatment, offering improved survival rates and enhanced patients’ quality of life. However, realizing the full potential of immunotherapy in clinical practice remains a challenge, as there is still plenty of room for modulating the complexity of the human immune system in favor of an antitumor immunogenicity. Nanotechnology, with its unique properties, holds promise in augmenting the efficacy of cancer immunotherapies in biotherapeutic protection and site- and time-controlled delivery of the immune modulator biologicals. Polymeric nanoparticles are promising biomaterials among different nanocarriers thanks to their robustness, versatility, and cost-efficient design and production. This perspective paper overviews critical concepts in nanometric advanced delivery systems applied to cancer immunotherapy. We focus on a detailed exploration of the current state of the art and trends in using poly(beta-aminoester) (pBAE) polymers for nucleic acid-based antitumor immunotherapies. Through different examples of the use of pBAE polymers reported in the literature, we revise the main advantages these polymers offer and some challenges to overcome. Finally, the paper provides insights and predictions on the path toward the clinical implementation of cancer nano-immunotherapies, highlighting the potential of pBAE polymers for advancements in this field., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Unveiling the contribution of histidine-end-terminal pBAEs to endosomal escape using super-resCLEM imaging

  • Navalón López, María
  • Andrian, Teodora
  • Albertazzi, Lorenzo
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Pujals, Sílvia
The success of gene therapy focuses on the development of efficient and safe carriers capable of overcoming cellular barriers to deliver genetic material to the nucleus. Poly(beta-amino ester) nanoparticles (pβAE NPs) are promising cationic polymers that can complex nucleic acids to form polyplexes, facilitating intracellular delivery. Among the key intracellular hurdles, endosomal escape remains one of the most critical and debated steps. While the incorporation of histidine into polyplex formulations has been proposed to enhance endosomal escape via proton buffering, definitive evidence of this process has remained elusive. To address this gap, a super-resolution correlative light and electron microscopy (CLEM) approach was employed to decipher the intracellular trafficking of pβAE NPs. Specifically, we compared two pβAE formulations, one incorporating a histidine-arginine end-capping structure (RH) and a control containing only arginine end-capping (R). Our findings revealed that RH polyplexes efficiently escaped endosomes at early timepoints and achieved cytosolic localization, whereas R polyplexes predominantly remained trapped within endo-lysosomal compartments, ultimately undergoing exocytosis or degradation, as confirmed by lysosome-specific staining. This study provides, for the first time, direct high-resolution evidence of histidine-mediated endosomal escape in gene therapy, underscoring the role of histidine in overcoming intracellular barriers. Moreover, it highlights the power of super-resolution correlative imaging techniques in elucidating the nanoscale trafficking of gene delivery systems, enabling more rational design of next generation nanocarriers., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Unravelling the role of individual components in pBAE/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations

  • Navalón López, María
  • Dols-Perez, Aurora
  • Grijalvo, Santiago
  • Fornaguera, Cristina
  • Borrós, Salvador
Oligopeptide end–modified poly(β-amino ester)s (OM-pBAEs) offer a means for the effective implementation of gene therapeutics in the near future. A fine-tuning of OM-pBAEs to meet application requirements is achieved by the proportional balance of oligopeptides used and provide gene carriers with high transfection efficacy, low toxicity, precise targeting, biocompatibility, and biodegradability. Understanding the influence and conformation of each building block at molecular and biological levels is therefore pivotal for further development and improvement of these gene carriers. Herein, we unmask the role of individual OM-pBAE components and their conformation in OM-pBAE/polynucleotide nanoparticles using a combination of fluorescence resonance energy transfer, enhanced darkfield spectral microscopy, atomic force microscopy, and microscale thermophoresis. We found that modifying the pBAE backbone with three end-terminal amino acids produces unique mechanical and physical properties for each combination. Higher adhesion properties are seen with arginine and lysine-based hybrid nanoparticles, while histidine provides an advantage in terms of construct stability. Our results shed light on the high potential of OM-pBAEs as gene delivery vehicles and provide insights into the influence of the nature of surface charges and the chemical nature of the pBAE modifications on their paths towards endocytosis, endosomal escape, and transfection., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Bovine serum albumin nanoparticles as a long-acting antiviral delivery platform for mycophenolic acid and ribavirin against emerging RNA viruses

  • Castañeda Cataña, Mayra Alejandra
  • Morrone, Josefina
  • Carlucci, Maria Josefina
  • Vásquez, Cecilia A.
  • Damonte, Elsa
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Sepúlveda, Claudia
Bovine serum albumin nanoparticles (BSA NP) encapsulating mycophenolic acid (MPA) and ribavirin (RBV) were developed as a sustained-release antiviral platform to address the limitations of conventional therapies against Zika (ZIKV) and Junín (JUNV) viruses. The BSA NP exhibited reproducible physicochemical properties, high drug loading efficiency, and excellent hemocompatibility (< 2% hemolysis). Cellular uptake studies revealed progressive internalization and prolonged intracellular retention, while antiviral assays demonstrated that encapsulated MPA and RBV maintained efficacy at 100- and 200-fold lower concentrations than their free forms, with activity lasting up to 96 h after a single dose. Furthermore, protein corona analysis with fibrinogen, albumin, and isoenzyme II showed how surface interactions influence NP stability and potential biodistribution. These findings are significant as they demonstrate that BSA represent a solid alternative to conventional treatments by sustaining intracellular levels and reducing systemic toxicity, offering a safe, biocompatible, and long-acting macromolecular platform for clinical antiviral applications. Overall, this study demonstrates that BSA-based NP constitute a non-immunogenic and effective long-acting delivery strategy that markedly enhances the intracellular exposure and antiviral performance of clinically validated broad-spectrum antivirals, supporting their potential as a solid alternative to conventional dosing regimens limited by toxicity and rapid clearance. In conclusion, BSA NPs represent a solid alternative to existing therapeutics by enhancing the therapeutic index of MPA and RBV, reducing systemic toxicity through controlled release, and providing a biocompatible platform for clinical antiviral applications., info:eu-repo/semantics/acceptedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unravelling the role of individual components in pBAE/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations

  • Navalón-López, María
  • Dols-Pérez, Aurora
  • Grijalvo, Santiago
  • Fornaguera, Cristina
  • Borrós, Salvador
Oligopeptide end-modified poly(β-amino ester)s (OM-pBAEs) offer a means for the effective implementation of gene therapeutics in the near future. A fine-tuning of OM-pBAEs to meet application requirements is achieved by the proportional balance of oligopeptides used and provide gene carriers with high transfection efficacy, low toxicity, precise targeting, biocompatibility, and biodegradability. Understanding the influence and conformation of each building block at molecular and biological levels is therefore pivotal for further development and improvement of these gene carriers. Herein, we unmask the role of individual OM-pBAE components and their conformation in OM-pBAE/polynucleotide nanoparticles using a combination of fluorescence resonance energy transfer, enhanced darkfield spectral microscopy, atomic force microscopy, and microscale thermophoresis. We found that modifying the pBAE backbone with three end-terminal amino acids produces unique mechanical and physical properties for each combination. Higher adhesion properties are seen with arginine and lysine-based hybrid nanoparticles, while histidine provides an advantage in terms of construct stability. Our results shed light on the high potential of OM-pBAEs as gene delivery vehicles and provide insights into the influence of the nature of surface charges and the chemical nature of the pBAE modifications on their paths towards endocytosis, endosomal escape, and transfection., The authors acknowledge the financial support received from MINECO (grant RTI2018-094734-B-C22 and BIGDATASPM PID2019-110210GB-I00), MICIN (grant RTC2019-007260-1), MCIN/AEI /10.13039/501100011033/FEDER, UE (grant PID2021-125910OB-I00) and Generalitat de Catalunya (2017 SGR 1559). A. D-P. received funding from the postdoctoral fellowships program Beatriu de Pinós, funded by the Secretary of Universities and Research (Government of Catalonia), and from the Horizon 2020 program of research and innovation of the European Union under the Marie Skłodowska-Curie grant agreement No 801370. S. G. thanks the Instituto de Salud Carlos III (ISCIII) (CB06/01/1058). CIBER BBN is an initiative funded by the VI National R + D + I Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER actions and financed by ISCIII with assistance from the European Regional Development Fund. The authors want to thank NANBIOSIS ICTS and the Nanostructured Liquid Characterization Unit (U12) for the characterization of materials by high-resolution optical microscopy with spectral analysis. Laura Olmo and Maria Stampa Lopez-Pinto are acknowledged for polymer synthesis. Maria Stampa Lopez-Pinto and Nil González-Rios are acknowledged for the NMR characterization of the polymers. The Nanothemper team is also acknowledged for their complimentary sample processing data of the NPs binding affinity results., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization

  • Losada Baranera, Mar
  • GOTOR, GEMMA
  • Borrós, Salvador
  • Fornaguera, Cristina
Messenger RNA (mRNA) has emerged as a transformative modality for modern therapeutics, including vaccines and gene therapies. Ensuring the quality, safety, and efficacy of mRNA products requires the evaluation of critical quality attributes (CQAs) such as sequence integrity, nucleotide modifications, purity, and structural stability. The growing complexity of modified mRNA therapeutics highlights the need for robust and orthogonal analytical strategies. This review summarizes liquid chromatography (LC)-based workflows tailored for mRNA characterization including UV detection and mass spectrometry (MS) strategies. These include nucleoside-level analysis to identify chemical modifications and impurities, partial digestion with oligonucleotide mapping to assess sequence coverage and localization of modifications, and intact mRNA analysis to evaluate global structural integrity and encapsulation efficiency. Case studies illustrate practical applications by directly linking analytical workflows to specific CQAs and regulatory-relevant attributes. By leveraging advances in chromatography and mass spectrometry—including bioinert stationary phases, high-resolution detection, and ion-pairing strategies—these studies enable robust analysis of highly polar, charged, and high-molecular-weight mRNA species. The integration of complementary chromatographic and MS-based workflows supports comprehensive characterization, facilitates regulatory compliance, and informs process and formulation development, ultimately providing a coherent framework for quality control in emerging mRNA therapeutics., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Balancing stability and cellular interaction in surface-engineered small extracellular vesicles for pulmonary delivery

  • Gomez Sanchez, Jose
  • Leivar, Pablo
  • Pinto, Soraia
  • Almeida, Helena
  • Artigues Cladera, Margalida
  • Sarmento, Bruno
  • Lecina, Martí
  • Fornaguera, Cristina
Small extracellular vesicles (sEVs) are emerging as promising nanocarriers for non-invasive pulmonary drug delivery, yet their effectiveness is limited by sequential barriers imposed by airway mucus and the pulmonary epithelium-endothelium interface. Here, we investigated how post-secretory surface engineering with exogenous phospholipids modulates sEVs transport across lung-relevant barriers. eGFP-CD81 engineered sEVs were post-secretory modified at their surface composition using different lipid-to-vesicle ratios of either the zwitterionic lipid 1,2- Dilauroyl-sn-glycero-3-phosphocholine (DLPC) or the PEGylated lipid 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) -PEG(5000) - Azide (DPA). Both modifications enabled controlled tuning of surface charge and colloidal stability without altering vesicle size at optimized lipid-to-vesicle ratios, although excessive DPA induced aggregation. The physicochemical properties and transport behaviour of engineered sEVs were evaluated in a reconstituted mucin gel and a 3D pulmonary epithelial-endothelial co-culture model. In mucin-containing medium, lipid-engineered sEVs showed enhanced diffusion compared with unmodified vesicles, with DLPC at a 30,000:1 ratio providing the highest cumulative permeability, sustained apparent permeability coefficients, and more diffusive motion profiles, as confirmed by multiple particle tracking. In the 3D co-culture, the same modification achieved the greatest cumulative permeability and basolateral accumulation, indicating efficient transcellular passage, while DPA-functionalized vesicles displayed moderate permeability and predominant retention at the apical epithelial layer. Through fluorescently-labelling EVs, we confirmed that all formulations were internalized by apical cells, but only DLPC-engineered sEVs reached detectable levels in basolateral cells. Neither DLPC nor DPA affected cell viability or barrier morphology. Overall, our results identify DLPC at 30,000:1 as a lead formulation that balances mucus penetration and efficient crossing of the pulmonary barrier, while DPA is better suited for applications requiring strong epithelial engagement. Our findings highlight rational phospholipid engineering as a powerful approach to tailor sEVs-based nanomedicines for pulmonary delivery., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Bovine serum albumin nanoparticles as a long-acting antiviral delivery platform for mycophenolic acid and ribavirin against emerging RNA viruses

  • Castañeda Cataña, Mayra Alejandra
  • Morrone, Josefina
  • Carlucci, Maria Josefina
  • Vásquez, Cecilia A.
  • Damonte, Elsa
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Sepúlveda, Claudia
Bovine serum albumin nanoparticles (BSA NP) encapsulating mycophenolic acid (MPA) and ribavirin (RBV) were developed as a sustained-release antiviral platform to address the limitations of conventional therapies against Zika (ZIKV) and Junín (JUNV) viruses. The BSA NP exhibited reproducible physicochemical properties, high drug loading efficiency, and excellent hemocompatibility (< 2% hemolysis). Cellular uptake studies revealed progressive internalization and prolonged intracellular retention, while antiviral assays demonstrated that encapsulated MPA and RBV maintained efficacy at 100- and 200-fold lower concentrations than their free forms, with activity lasting up to 96 h after a single dose. Furthermore, protein corona analysis with fibrinogen, albumin, and isoenzyme II showed how surface interactions influence NP stability and potential biodistribution. These findings are significant as they demonstrate that BSA represent a solid alternative to conventional treatments by sustaining intracellular levels and reducing systemic toxicity, offering a safe, biocompatible, and long-acting macromolecular platform for clinical antiviral applications. Overall, this study demonstrates that BSA-based NP constitute a non-immunogenic and effective long-acting delivery strategy that markedly enhances the intracellular exposure and antiviral performance of clinically validated broad-spectrum antivirals, supporting their potential as a solid alternative to conventional dosing regimens limited by toxicity and rapid clearance. In conclusion, BSA NPs represent a solid alternative to existing therapeutics by enhancing the therapeutic index of MPA and RBV, reducing systemic toxicity through controlled release, and providing a biocompatible platform for clinical antiviral applications., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of mitochondrial apoptosis via siRNA-loaded metallo-alginate hydrogels: A localized and synergistic antitumor therapy

  • Fernandez Alarcon, Jennifer
  • Artigues Cladera, Margalida
  • Rodriguez Camenforte, Natalia
  • Sitia, Giovanni
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Preventing relapse after resection of a primary tumor continues to be an unmet clinical need. Development of adjuvant biomaterials with the capacity to kill residual cancer cells after tumor resection is of clinical importance. Here we developed a library of metallo-alginate hydrogels containing high concentrations of metallic ions such as Ca2+ in combination with Zn2+, Li+, or Mg2+ to disrupt Ca2+ homeostasis in the mitochondria of cancer cells by local hyperthermia. To synergistically kill tumor cells and suppress the growth of rechallenged tumors, we embedded oncogene-silencing nucleic acids (mTOR siRNA) loaded into polymerc nanoparticles (NPs) composed of poly (β-amino esters) in the metallo-alginate hydrogels, targeting cancer cells that activate multi-drug resistance pathways such PI3K/AKT/mTOR. Metabolomic studies showed alterations in the Warburg effect, mitochondrial transport, and the TCA cycle, confirming cancer cell damage. In vivo studies of this targeted therapy in mice demonstrated a sex-dependent effect. Male B16F10-tumor-bearing mice treated with the synergistic therapy showed restrained tumor growth. In contrast, no therapeutic effect was observed in female counterparts. Our results demonstrate that in situ-formed NP-loaded metallo-alginate hydrogels can modulate two distinct immune signaling networks that are relevant for enhancing cancer cell death. On the basis of our findings, this combination therapy emerges as a promising sex-dependent strategy for clinical translation., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from Plectranthus grandidentatus Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera
  • Morais, João
  • Fernandez Alarcon, Jennifer
  • S. Viana, Ana
  • Reis, Catarina
  • Pereira Leite, Catarina
  • Ana M., Díaz Lanza
  • Saraiva, Lucília
  • Fornaguera, Cristina
  • Rijo, Patrícia Dias de Mendonça
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics, the good, the bad, and the future

  • Magana Rodriguez, Jose Rodrigo
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Immunotherapy has emerged as a promising approach to cancer treatment, offering improved survival rates and enhanced patients’ quality of life. However, realizing the full potential of immunotherapy in clinical practice remains a challenge, as there is still plenty of room for modulating the complexity of the human immune system in favor of an antitumor immunogenicity. Nanotechnology, with its unique properties, holds promise in augmenting the efficacy of cancer immunotherapies in biotherapeutic protection and site- and time-controlled delivery of the immune modulator biologicals. Polymeric nanoparticles are promising biomaterials among different nanocarriers thanks to their robustness, versatility, and cost-efficient design and production. This perspective paper overviews critical concepts in nanometric advanced delivery systems applied to cancer immunotherapy. We focus on a detailed exploration of the current state of the art and trends in using poly(beta-aminoester) (pBAE) polymers for nucleic acid-based antitumor immunotherapies. Through different examples of the use of pBAE polymers reported in the literature, we revise the main advantages these polymers offer and some challenges to overcome. Finally, the paper provides insights and predictions on the path toward the clinical implementation of cancer nano-immunotherapies, highlighting the potential of pBAE polymers for advancements in this field., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Unravelling the role of individual components in pBAE/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations

  • Navalón López, María
  • Dols-Perez, Aurora
  • Grijalvo, Santiago
  • Fornaguera, Cristina
  • Borrós, Salvador
Oligopeptide end–modified poly(β-amino ester)s (OM-pBAEs) offer a means for the effective implementation of gene therapeutics in the near future. A fine-tuning of OM-pBAEs to meet application requirements is achieved by the proportional balance of oligopeptides used and provide gene carriers with high transfection efficacy, low toxicity, precise targeting, biocompatibility, and biodegradability. Understanding the influence and conformation of each building block at molecular and biological levels is therefore pivotal for further development and improvement of these gene carriers. Herein, we unmask the role of individual OM-pBAE components and their conformation in OM-pBAE/polynucleotide nanoparticles using a combination of fluorescence resonance energy transfer, enhanced darkfield spectral microscopy, atomic force microscopy, and microscale thermophoresis. We found that modifying the pBAE backbone with three end-terminal amino acids produces unique mechanical and physical properties for each combination. Higher adhesion properties are seen with arginine and lysine-based hybrid nanoparticles, while histidine provides an advantage in terms of construct stability. Our results shed light on the high potential of OM-pBAEs as gene delivery vehicles and provide insights into the influence of the nature of surface charges and the chemical nature of the pBAE modifications on their paths towards endocytosis, endosomal escape, and transfection., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ammonium trifluoroborate-modified poly(β-aminoesters): A case study for PET-guided in vivo pharmacokinetic studies of a non-viral gene delivery system

  • Cosialls, Raúl
  • Fernández, Odile
  • Simó , Cristina
  • Krishna Reddy, Pulagam
  • Guerra-Rebollo, Marta
  • Llop, Jordi
  • Fornaguera, Cristina
  • Cuenca, Ana Belen
  • Borrós, Salvador
Nucleic acid-based therapies have become a game-changing player in our way of conceiving pharmacology. Nevertheless, the inherent lability of the phosphodiester bond of the genetic material with respect to the blood nucleases severely hampers its delivery in naked form, therefore making it necessary to use delivery vectors. Among the potential non-viral vectors, polymeric materials such as the poly(β-aminoesters) (PBAEs) stand out as promising gene carriers thanks to their ability to condense nucleic acids in the form of nanometric polyplexes. To keep advancing these systems into their translational preclinical phases, it would be highly valuable to gain accurate insights of their in vivo pharmacokinetic profile. We envisaged that positron emission tomography (PET)-guided imaging could provide us with both, an accurate assessment of the biodistribution of PBAE-derived polyplexes, as well shed light on their clearance process. In this sense, taking advantage of the efficient [19F]-to-[18F]‑fluorine isotopic exchange presented by the ammonium trifluoroborate (AMBF3) group, we have designed and synthesized a new 18F-PET radiotracer based on the chemical modification of a linear poly(β-aminoester). As proof of concept, the incorporation of the newly developed 18F-PBAE into a model nanoformulation was shown to be fully compatible with the formation of the polyplexes, their biophysical characterization, and all their in vitro and in vivo functional features. With this tool in hand, we were able to readily obtain key clues about the pharmacokinetic behavior of a series of oligopeptide-modified PBAEs (OM-PBAEs). The observations described in this study allow us to continue supporting these polymers as an outstanding non-viral gene delivery vector for future applications., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers

  • Fernandez Alarcon, Jennifer
  • Rata Karusan , Nisha
  • Presciutti, Clara
  • Miras, Jonathan
  • Magana Rodriguez, Jose Rodrigo
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Ahmad, Noraini
  • Fornaguera, Cristina
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovitis, systemic inflammation and autoantibodies, leading to joint damage and disability. RA pathogenesis is characterized by a dysregulated interaction between immune cells, particularly B cells and T cells, which release inflammatory cytokines. This review explores the pivotal role of these immune cells in sustaining the inflammatory response and contributing to tissue injury. We provide a comprehensive overview of current RA therapies, highlighting the limitations of conventional treatments and the pressing need for targeted drug delivery systems such as lipid nanocarrier-based therapies, including nano-emulsions, solid lipid nanoparticles (SLNs), niosomes, liposomes, transferosomes, and ethosomes. Emphasizing niosomes, we discuss their capacity to encapsulate multiple drugs, significantly enhancing bioavailability and therapeutic efficacy. By directing drug-loaded niosomes to inflamed synovial sites, this innovative approach minimizes systemic side effects while maximizing localized drug concentrations, thereby optimizing treatment outcomes for RA patients. This review underscores the importance of targeted (nano)drug delivery in improving patient's life quality and represents a significant step toward more effective, personalized RA therapies by deepening our understanding of the underlying mechanisms., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PExM: polyplex expansion microscopy for cell trafficking studies

  • Navalón López, María
  • Castells Colldeforns, Pau
  • Pujals, Sílvia
  • Fornaguera, Cristina
  • Borrós, Salvador
Nanomedicine is a field at the intersection of nanotechnology and medicine, promising due to its potential to revolutionize healthcare. Despite its long trajectory, there is still a long road ahead for its full development, and smart design of nanomedicines is still a challenge. Among other problems, this is due to the scarcity of tools available for the precise visualization and comprehension of nano–bio interactions, impeding progress towards the clinical phase. One of the developed tools that stands out to be a strong nanoscopy technique for studying nano-delivery systems within cellular environments is expansion microscopy (ExM). This technique was used for tissue and cell expansion and most recently for lipid molecule expansion inside cells. Herein, we present for the first time polyplex expansion microscopy (PExM); a comprehensive examination of ExM as an already developed technique, but adapted for expanding polymer based nanocarriers, in particular polyplexes within cells, allowing the analysis of their trafficking. With our method set up, PExM will be extensively used for the study of polyplex nanoparticle cell trafficking, becoming a high-resolution technique which can also be applied to primary amine containing polymeric nanoparticles without requiring expensive super-resolution microscopes., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A dual QTOF–QTrap analytical platform for comprehensive tracking of doxycycline and its degradation byproducts in biological and nanoparticle-based delivery systems

  • Bofill Bonet, Carles
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà, Noemí
  • Martorell, Jordi
  • Fornaguera, Cristina
  • Borrós, Salvador
Doxycycline (DOX) is a second-generation tetracycline antibiotic extensively used in clinical practice, not only for its antimicrobial activity but also for its emerging therapeutic potential in modulating extracellular matrix (ECM) in remodeling processes. Increasing evidence supports its role in attenuating pathological conditions associated with ECM degradation by targeting matrix metalloproteinases type 2 (MMP-2), including cancer progression and abdominal aortic aneurysm (AAA). However, DOX exhibits limited stability in aqueous and semi-physiological environments, undergoing hydrolysis and oxidative reactions that lead to the generation of multiple degradation byproducts, thereby compromising its efficacy and safety profile. In this study, we systematically mapped the degradation pathways of DOX under rigorously controlled physicochemical and biological conditions. High-resolution QTOF mass spectrometry operating in SWATH data-independent acquisition mode enabled unbiased identification of multiple, structurally distinct degradation byproducts, as well as the DOX parent compound, using curated metabolite libraries from SCIEX platform. Building on this annotation step, we established a complementary QTrap-based targeted workflow to quantify low-abundance metabolites intra- and extracellular through isotope-specific transitions derived from the QTOF analysis and to monitor their temporal kinetics with high sensitivity. Together, this integrated analytical strategy provides refined insight into the intrinsic instability of DOX and its potential biological consequences. To translate degradation mapping into a biologically relevant context, OM-PLGA NPs were incorporated as a controlled delivery platform that modulates DOX exposure, slows spontaneous degradation, and creates the matrix conditions required to validate the sensitivity of the QTRAP workflow in complex cellular environments. This validation demonstrated that OM-PLGA nanoparticles not only preserve DOX in its bioactive form through microenvironmental shielding, but also results in enhanced pharmacological activity, particularly sustained inhibition of MMP-2, a central enzyme in AAA-associated ECM remodeling. Together, these results highlight the dual value of the advanced analytical workflow and the nanocarrier strategy, demonstrating how integrating high-resolution mass spectrometry with nanoparticle engineering overcomes the intrinsic instability of DOX and provides deeper mechanistic insight across both analytical and biological dimensions., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Localized doxycycline delivery via polymeric nanoparticles anchored to electrospun PCL microfiber patch for MMP-2 inhibition in abdominal aortic aneurysm

  • Bofill Bonet, Carles
  • Febas, Germán
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà Palasí, Noemí
  • Martorell, Jordi
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxycycline (DOXY) is a well-established antibiotic that has recently shown potential in inhibiting matrix metalloproteinase-2 (MMP-2), a key enzyme involved in the progression of abdominal aortic aneurysms (AAA). However, the controlled delivery of DOXY to the aneurysm site, with sustained release and minimal systemic exposure, remains a critical challenge in therapeutic development. To address this, we developed a targeted drug delivery platform based on polymeric nanoparticles (NPs), prepared from water-in-oil-in-water nano-emulsions, encapsulating DOXY and are covalently attached to electrospun ε-poly(caprolactone) (ε-PCL) microfibers. This system was designed to enable local, sustained drug release in the inner wall of aorta while preserving the mechanical properties of the aortic wall. The ε-PCL electrospun microfibers from the patch were first functionalized using oxygen cold plasma treatment, creating free radicals that enabled covalent bonding with chemical groups on the outer layer of DOXY-loaded poly(lactic-co-glycolic acid) (PLGA) NPs. This strategy allowed for robust immobilization of the NPs onto the microfibers surface, forming a composite system capable of localized and controlled drug release over time. Unlike traditional delivery approaches, this method ensures site-specific action of DOXY directly at the aneurysmal tissue, minimizing systemic circulation and reducing off-target toxicity. The platform not only provides a stable drug reservoir but also offers intrinsic biomechanical reinforcement, which is critical in AAA condition. This innovative delivery system represents a significant advance in the localized treatment of vascular disorders. It offers a biocompatible, biodegradable, and precisely targeted therapeutic approach, with potential to reduce the need for surgical intervention and limits the adverse effects associated with systemic drug administration., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles

  • Guarro, Monica
  • van Veen, Stijn
  • Borrós, Salvador
  • Albertazzi, Lorenzo
  • Lecina, Martí
  • Fornaguera, Cristina
Extracellular vesicles (EVs) are increasingly recognized as natural therapeutic delivery systems (DDS). A critical challenge in realizing this potential is the loading of nucleic acids, particularly mRNA, a high molecular weight and very sensitive biomolecule, for which the loading efficiency into EVs is often low. Despite the growing interest in EV-based delivery platforms, relatively few studies have reported efficient loading techniques, and inconsistent or misleading information in the literature hinders progress towards the development of reliable loading of mRNA into EV-based systems. Addressing this gap systematically and quantitatively is crucial for the clinical translation of EVs as DDS. In this study, we compared five different exogenous mRNA loading methods (incubation, sonication, freeze-thaw, electroporation and extrusion) and evaluated their loading efficiencies, as well as their biophysical, biochemical, and functional properties. Here, using direct stochastic optical reconstruction microscopy (dSTORM), as an efficient and reliable characterization approach to assess mRNA loading efficiency into EVs we visualized single EVs and single mRNA molecules and to estimate the percentage of loaded EVs as well as the amount of mRNA molecules loaded per EV. Interestingly, all five strategies demonstrated a high yield of EVs associated with mRNA, with up to 70 % of EVs successfully containing or in contact with mRNA, with minimal disruption to the intrinsic properties of EVs. Although some discrepancies between loading efficiencies, functionality and amount of mRNA molecules per EV, freeze-thaw proved to be the most effective in terms of loading efficiency and amount of mRNA associated molecules per EV. Overall, mRNA incorporation using these exogenous methods remained inefficient and presented significant challenges for large-scale implementation due to substantial mRNA loss. Despite this limitation, the high proportion of successfully loaded or mRNA associated EVs, particularly with freeze-thaw and electroporation, provides, for the first time, a promising foundation for the advancing of mRNA loading on EV-based therapeutic applications., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Unveiling the contribution of histidine-end-terminal pBAEs to endosomal escape using super-resCLEM imaging

  • Navalón López, María
  • Andrian, Teodora
  • Albertazzi, Lorenzo
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Pujals, Sílvia
The success of gene therapy focuses on the development of efficient and safe carriers capable of overcoming cellular barriers to deliver genetic material to the nucleus. Poly(beta-amino ester) nanoparticles (pβAE NPs) are promising cationic polymers that can complex nucleic acids to form polyplexes, facilitating intracellular delivery. Among the key intracellular hurdles, endosomal escape remains one of the most critical and debated steps. While the incorporation of histidine into polyplex formulations has been proposed to enhance endosomal escape via proton buffering, definitive evidence of this process has remained elusive. To address this gap, a super-resolution correlative light and electron microscopy (CLEM) approach was employed to decipher the intracellular trafficking of pβAE NPs. Specifically, we compared two pβAE formulations, one incorporating a histidine-arginine end-capping structure (RH) and a control containing only arginine end-capping (R). Our findings revealed that RH polyplexes efficiently escaped endosomes at early timepoints and achieved cytosolic localization, whereas R polyplexes predominantly remained trapped within endo-lysosomal compartments, ultimately undergoing exocytosis or degradation, as confirmed by lysosome-specific staining. This study provides, for the first time, direct high-resolution evidence of histidine-mediated endosomal escape in gene therapy, underscoring the role of histidine in overcoming intracellular barriers. Moreover, it highlights the power of super-resolution correlative imaging techniques in elucidating the nanoscale trafficking of gene delivery systems, enabling more rational design of next generation nanocarriers., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Safety of nanoparticle therapies during pregnancy: a systematic review and meta-analysis

  • Gil-Vives, Maria
  • Hernández, Marta
  • Hernáez, Álvaro
  • Borrós, Salvador
  • Fornaguera, Cristina
The exclusion of pregnant women from clinical trials has led to insufficient safety data for many treatments, making it necessary to evaluate their potential benefits and risks during preclinical stages. Nanomedicines show potential for reduced toxicity but there is limited evidence about their safety for pregnant women and their fetuses. We conducted the first systematic review and meta-analysis of the effect of nanoparticles (NPs) on a key outcome of fetal toxicity (low birth weight) in murine models. In the meta-analysis of mouse models, negatively charged NPs tended to decrease birth weight (-69.8 mg, 95 % CI: -196 to 56.5), as did small (-191 mg, 95 % CI: -369 to -13.3) and plain inorganic nanosystems (-249 mg, 95 % CI: -535 to 37.4). In contrast, positively charged NPs resulted in increased birth weight (+29.3 mg, 95 % CI: 23.4 to 35.2). All findings were validated in studies with low heterogeneity and low risk of publication bias. Neither large NPs (+4.37 mg; 95 % CI: -45.3 to 54.0) nor polymer-coated NPs (+16.5 mg; 95 % CI: -44.7 to 77.6) had any clear association with birth weight. Similar results were observed in other models and experimental designs from articles not included in the meta-analysis, although no conclusions were drawn for other parameters due to high variability. Our findings pave the way for future research and the rational development of safer nanomedicines for use during pregnancy., Agencia Estatal de Investigación MICIN / AEI, grants: PID2021-125910OB-I00, MCIN/AEI and 10.13039/501100011033 / FEDER, UE (CFP).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Novel α-mannose-functionalized poly(β-amino ester) nanoparticles as mRNA vaccines with increased antigen presenting cell selectivity in the spleen

  • González-Ríos, Nil
  • Artigues Cladera, Margalida
  • Guerra-Rebollo, Marta
  • Planas, Antoni
  • Borrós, Salvador
  • Faijes, Magda
  • Fornaguera, Cristina
mRNA vaccination has emerged as a prominent therapy for the future of medicine. Despite the colossal advance in this technology and worldwide efficacy proof (ca. COVID vaccines), mRNA carriers still lack cell/tissue specificity, leading to possible side effects, and reduced efficacy among others. Herein we make use of the ubiquitous affinity of antigen-presenting cells (APC)s for glycosides to achieve specific targeting. To achieve this goal, we designed a new generation of α-mannosyl functionalized oligopeptide-terminated poly(β-aminoester). Fine formulation of these polymers with mRNA resulted in nanoparticles decorated with surface-exposed α-mannoses with sizes around 180 nm and positive surface charge. Notably, these particles maintained their properties after freeze-drying and subsequent redispersion. Finally, our mRNA carriers preferentially targeted and transfected APCs in vitro and in vivo. In conclusion, we demonstrated, at a preclinical level, that the mannose functionalization enables more selective targeting of APCs and, thus, these polymer and nanoparticles are candidates for a new generation of mRNA immunotherapy vaccines., info:eu-repo/semantics/publishedVersion
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from "Plectranthus grandidentatus" Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera M. S.
  • Morais, João
  • Fernández Alarcón, Jennifer
  • Viana, Ana S.
  • Pinto Reis, Catarina
  • Pereira Leite, Catarina
  • Díaz Lanza, Ana María|||0000-0002-4216-3997
  • Saraiva, Lucília
  • Fornaguera, Crisitna
  • Dias de Mendonça Rijo, Patricia
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., Fundação para a Ciência e a Tecnologia (FCT), AGAUR-Generalitat de Catalunya, ACCIO-Generalitat de Catalunya, Generalitat de Catalunya, Agencia Estatal de Investigación